Search for: "Novartis Pharmaceuticals Corp. v. Abbott Laboratories, Inc."
Results 21 - 40
of 45
Sorted by Relevance
|
Sort by Date
22 Apr 2010, 3:51 am
Paddock Laboratories, Inc. [read post]
27 May 2010, 3:20 am
Idexx Reference Laboratories, Inc. et al.; Pieczenik v. [read post]
2 Dec 2011, 2:00 pm
Novartis Pharmaceuticals Corp., ___ Fed. [read post]
5 Apr 2013, 1:01 pm
Abbott Laboratories, C.A. [read post]
13 May 2010, 12:27 pm
Novartis Pharmaceuticals Corp., 642 F. [read post]
11 Jan 2008, 9:00 am
: (IP Spotlight)PharmaIndia: Trade mark assignment under scrutiny in a case of deceptive similarity - Doctor Morepen Limited v Yash Pharma Laboratories Limited: (Mondaq),Arrow v Merck - An early route to market for generics? [read post]
24 Aug 2015, 5:00 am
Abbott Laboratories, Inc., ___ F. [read post]
30 Dec 2013, 5:25 am
Takeda Pharmaceutical Co. [read post]
29 Dec 2010, 2:57 am
Ferring Pharmaceuticals, Inc et al. [read post]
22 Dec 2011, 11:59 am
Novartis Pharmaceuticals Corp., 793 F. [read post]
2 Oct 2008, 12:36 pm
Novartis Pharmaceuticals Corp., 283 F.3d 254, 266-68 (5th Cir. 2002), where the court didn't let the plaintiff get away with arguing that there should have been a warning about "liver failure" and "death" in addition to "hepatitis. [read post]
28 Dec 2012, 1:57 pm
Centocor, Inc. v. [read post]
22 Jan 2009, 2:06 am
Alad Corp., 19 Cal.3d 22, 31 (1977). [read post]
21 Dec 2012, 11:41 am
Janssen Pharmaceutical, Inc., ___ So.3d___, 2012 WL 3761900 (La. [read post]
25 Jan 2008, 1:00 am
: (Generic Pharmaceuticals & IP),Arava (Leflunomide) - Sanofi-Aventis loses bid to dismiss Louisiana Wholsesale Drug Co's antitrust claims accusing S-A of unlawfully blocking generic competition for Arava by filing a sham Citizen Petition with the USFDA: (IP Law360),Ciprofloxacin - CIPLA issued notice by National Pharmaceutical Pricing Authority for allegedly overpricing its antibiotic Ciprofloxacin (especially of note because CIPLA … [read post]
30 Jun 2011, 5:00 am
Wyeth Laboratories, 510 F. [read post]
28 Oct 2011, 7:00 am
Mylan Pharmaceuticals, Inc., 751 F. [read post]
18 Jul 2008, 8:34 am
: (Patent Circle), Tanzania to conduct study on impact of counterfeit medicines: (Afro-IP), US: New rules on generic biological medicines under US Congressional debate: (Intellectual Property Watch), Pharma & Biotech - Products Acular (Ketorolac) – US: CAFC rules against Apotex reverse doctrine of equivalents: Roche Palo Alto & Allergan, Inc v Apotex: (Patent Circle), Carbatrol (Carbamazapine) – US: Federal judge allows Corepharma to seek DJ… [read post]
4 Apr 2008, 1:00 am
: (IPBiz) Pharma & Biotech - Products Abilify (Aripiprazole) – Otsuka files US patent infringement suit against Teva over seeking approval for generic Abilify: (IP Law360), Aricept (Donepezil) – US federal judge grants Eisai’s request for preliminary injunction blocking Teva from marketing generic version of Aricept: (IP Law360), (Orange Book Blog), Carbatrol (Carbamazepine) – US federal judge delivers mixed ruling in Shire… [read post]
11 Nov 2022, 9:40 am
Novartis Pharmaceuticals Corp., Case No. 17-cv-04405-HSG, Document 565, July 22,2021 (N.D. [read post]
